Literature DB >> 19448665

Astrocyte elevated gene-1 contributes to the pathogenesis of neuroblastoma.

S-G Lee1, H-Y Jeon, Z-Z Su, J E Richards, N Vozhilla, D Sarkar, T Van Maerken, P B Fisher.   

Abstract

Neuroblastoma, derived from neural crest progenitor cells, is the most common extracranial solid tumor of childhood. Astrocyte elevated gene-1 (AEG-1) is a primary mediator of tumor progression and metastasis in several human cancers. In this study, we investigated the potential contribution of AEG-1 in human neuroblastoma pathogenesis. AEG-1 expression was significantly elevated in neuroblastoma patient-derived samples and neuroblastoma cell lines as compared with normal peripheral nerve tissues, normal astrocytes and immortalized melanocytes. Knockdown of AEG-1 by small interfering RNA reduced the tumorigenic properties of highly aggressive neuroblastoma cells. Conversely, over-expression of AEG-1 enhanced proliferation and expression of the transformed state in less aggressive neuroblastoma cells through activation of the phosphatidylinositol 3-kinase-Akt-signaling pathway and stabilization of MYCN. These provocative results indicate that AEG-1 may play a crucial role in the pathogenesis of neuroblastoma and could represent a potential target for therapeutic intervention.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19448665     DOI: 10.1038/onc.2009.93

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  59 in total

Review 1.  Thinking about HIV: the intersection of virus, neuroinflammation and cognitive dysfunction.

Authors:  K Grovit-Ferbas; M E Harris-White
Journal:  Immunol Res       Date:  2010-12       Impact factor: 2.829

2.  Knockdown of Astrocyte Elevated Gene-1 Inhibits Activation of Hepatic Stellate Cells.

Authors:  Lei Chen; Yong-Ze Guo; Ai-di Li; Jun-Ji Ma; Hui-Yao Hao; Di Zhang; Yan Wang; Chen-Guang Ji; Wei Qi; Jia Wang; Hui-Qing Jiang
Journal:  Dig Dis Sci       Date:  2016-02-15       Impact factor: 3.199

3.  Depletion of astrocyte elevated gene-1 suppresses tumorigenesis through inhibition of Akt activity in bladder cancer cells.

Authors:  Lianhua Zhang; Guoliang Yang; Haige Chen; Yiran Huang; Wei Xue; Juanjie Bo
Journal:  Am J Transl Res       Date:  2017-12-15       Impact factor: 4.060

Review 4.  The role of AEG-1/MTDH/LYRIC in the pathogenesis of central nervous system disease.

Authors:  Evan K Noch; Kamel Khalili
Journal:  Adv Cancer Res       Date:  2013       Impact factor: 6.242

5.  Astrocyte elevated gene-1 is a novel modulator of HIV-1-associated neuroinflammation via regulation of nuclear factor-κB signaling and excitatory amino acid transporter-2 repression.

Authors:  Neha Vartak-Sharma; Benjamin B Gelman; Chaitanya Joshi; Kathleen Borgamann; Anuja Ghorpade
Journal:  J Biol Chem       Date:  2014-05-22       Impact factor: 5.157

6.  Upregulation of AEG-1 Involves in Schwann Cell Proliferation and Migration After Sciatic Nerve Crush.

Authors:  Youhua Wang; Weidong Zhang; Xudong Zhu; Yi Wang; Xingxing Mao; Xinbao Xu; Youhua Wang
Journal:  J Mol Neurosci       Date:  2016-06-28       Impact factor: 3.444

7.  Astrocyte-elevated gene-1 mediates insulin-like growth factor 1-induced the progression of cardiac myxoma.

Authors:  Changcun Fang; Yuwen Shen; Peng Qi; Zhengqin Liu; Min Zhang; Xinyan Pang
Journal:  Tumour Biol       Date:  2015-07-10

Review 8.  Astrocyte elevated gene-1: far more than just a gene regulated in astrocytes.

Authors:  Devanand Sarkar; Luni Emdad; Seok-Geun Lee; Byoung Kwon Yoo; Zao-Zhong Su; Paul B Fisher
Journal:  Cancer Res       Date:  2009-11-10       Impact factor: 12.701

9.  Serum anti-AEG-1 auto-antibody is a potential novel biomarker for malignant tumors.

Authors:  Xi Chen; Ke Dong; Min Long; Fang Lin; Xi Wang; Junxia Wei; Jihong Ren; Huizhong Zhang
Journal:  Oncol Lett       Date:  2012-05-25       Impact factor: 2.967

10.  Astrocyte elevated gene-1: a novel target for human glioma therapy.

Authors:  Luni Emdad; Devanand Sarkar; Seok-Geun Lee; Zhao Zhong Su; Byoung Kwon Yoo; Rupesh Dash; Adly Yacoub; Christine E Fuller; Khalid Shah; Paul Dent; Jeffrey N Bruce; Paul B Fisher
Journal:  Mol Cancer Ther       Date:  2010-01-06       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.